Efficacy of Omega-3 Fatty Acid Supplementation on Improvement of Bipolar Symptoms: A Systematic Review

      The purpose of this review was to examine the current level of evidence regarding the efficacy of omega-3 fatty acid supplementation in improving bipolar disorder symptoms. Of 99 articles meeting initial search criteria, 5 randomized control trials and 2 quasi-experimental studies were selected for review. Omega-3 fatty acid supplementation was effective in 4 of 7 studies. Those using an omega-3 combination of eicosapentaenoic acid and docosahexanoic acid demonstrated a statistically significant improvement in bipolar symptoms, whereas those using a single constituent did not. Dosage variations did not demonstrate statistically significant differences. Due to its benign side effect profile and some evidence supporting its usefulness in bipolar illness, omega-3 may be a helpful adjunct in treatment of selected patients. Future studies are needed to conclusively confirm the efficacy of omega-3s in bipolar disorder, uncovering a new well-tolerated treatment option.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Archives of Psychiatric Nursing
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Balk E.M.
        • Lichtenstein A.H.
        • Chung M.
        • Kupelnick B.
        • Chew P.
        • Lau J.
        Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: A systematic review.
        Atherosclerosis. 2006; 189: 19-30
        • Frangou S.
        • Lewis M.
        • McCrone P.
        Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: Randomized double-blind placebo-controlled study.
        The British Journal of Psychiatry. 2006; 188: 46-50
        • Hartweg J.
        • Farmer A.J.
        • Holman R.R.
        • Neil H.A.
        Meta-analysis of the effects of n-3 polyunsaturated fatty acids on haematological and thrombogenic factors in type 2 diabetes.
        Diabetologia. 2007; 50: 250-258
        • Hirashima F.
        • Parow A.M.
        • Stoll A.L.
        • Demopulos C.M.
        • Damico K.E.
        • Rohan M.L.
        • et al.
        Omega-3 fatty acid treatment and T2 whole brain relaxation times in bipolar disorder.
        American Journal of Psychiatry. 2004; 161: 1922-1926
        • Hodge W.G.
        • Barnes D.
        • Schachter H.M.
        • Pan Y.I.
        • Lowcock E.C.
        • Zhang L.
        • et al.
        The evidence for efficacy of omega-3 fatty acids in preventing or slowing the progression of retinitis pigmentosa: A systematic review.
        Canadian Journal of Ophthalmology. 2006; 41: 481-490
        • Hodge W.G.
        • Barnes D.
        • Schachter H.M.
        • Pan Y.I.
        • Lowcock E.C.
        • Zhang L.
        • et al.
        Evidence for the effect of omega-3 fatty acids on progression of age-related macular degeneration: A systematic review.
        Retina. 2007; 27: 216-221
        • Iglesias del Sol A.
        • Smulders Y.M.
        Health effects of fish oil and fish oil supplements: Consumption advice sustained.
        Ned Tijdschr Geneeskd. 2006; 150: 2069-2071
        • Jadad R.
        • Moore R.A.
        • Carrol D.
        • Jenkinson C.
        • Reynolds D.
        • Gavaghan D.J.
        Assessing the quality of reports of randomized clinical trials: Is blinding necessary?.
        Controlled Clinical Trials. 1996; 17: 1-12
        • Keck P.
        • Mintz J.
        • McElroy S.L.
        • Freeman M.P.
        • Suppes T.
        • Frye M.A.
        • et al.
        Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.
        Biological Psychiatry. 2006; 60: 1020-1033
        • Lieberman J.A.
        • Stroup S.
        • Mcevoy J.P.
        • Swartz M.S.
        • Rosenheck R.A.
        • Perkins D.O.
        • et al.
        Effectiveness of antipsychotic drugs in patients with chronic schizophrenia.
        New England Journal of Medicine. 2005; 353: 1209-1223
        • Lin P.Y.
        • Su K.P.
        A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids.
        Journal of Clinical Psychiatry. 2007; 68: 1056-1061
        • Marangell L.B.
        • Suppes T.
        • Ketter T.A.
        • Dennehy E.B.
        • Zboyan H.
        • Kertz B.
        • et al.
        Omega-3 fatty acids in bipolar disorder: Clinical and research considerations.
        Prostaglandins, Leukotrienes and Essential Fatty Acids. 2006; 75: 315-321
        • Osher Y.
        • Bersudsky Y.
        • Belmaker R.H.
        Omega-3 eicosapentaenoic acid in bipolar depression: Report of a small open-label study.
        Journal of Clinical Psychiatry. 2005; 66: 726-729
        • Sagduyu K.
        • Dokucu M.E.
        • Eddy B.A.
        • Craigen G.
        • Baldassano C.F.
        • Yildiz A.
        Omega-3 fatty acids decreased irritability of patients with bipolar disorder in an add-on, open label study.
        Nutrition Journal. 2005; 4: 6
        • Sajatovic M.
        • Valenstein M.
        • Blow F.C.
        • Ganoczy D.
        • Ignacio R.V.
        Treatment adherence with antipsychotic medications in bipolar disorder.
        Bipolar Disorders. 2006; 8: 232-241
        • Schachter H.M.
        • Kourad K.
        • Merali Z.
        • Lumb A.
        • Tran K.
        • Miguelez M.
        Effects of omega-3 fatty acids on mental health.
        Evidence Reports and Technology Assessments(Summary). 2005; 116: 1-11
        • Stoll A.L.
        • Severus W.E.
        • Freeman M.P.
        • Rueter S.
        • Zboyan H.A.
        • Diamond E.
        • et al.
        Omega 3 fatty acids in bipolar disorder.
        Archives of General Psychiatry. 1999; 56: 407-412
        • Studer M.
        • Briel M.
        • Leimenstoll B.
        • Glass T.R.
        • Bucher H.C.
        Effect of different antilipidemic agents and diets on mortality: A systematic review.
        Archives of Internal Medicine. 2005; 165: 725-730
        • Williams A.L.
        • Katz D.
        • Ali A.
        • Girard C.
        • Goodman J.
        • Bell I.
        Do essential fatty acids have a role in the treatment of depression?.
        Journal of Affective Disorders. 2006; 93: 117-123